People · Operator

David J. Maffei

Named in public records as an officer, director or promoter · active 2017–2018 · Other Technology

1
Companies
3
Filings
$12.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Akumina Inc.Other TechnologySeries A$12.9M$54.9M2017
Operator network

David J. Maffei at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Ali Diaz · 1 companies · 1 sharedAli DiazAli J. Riaz · 1 companies · 1 sharedAli J. RiazDaniel T. Monfried · 1 companies · 1 sharedDaniel T. MonfriedDavid T. Maffei · 1 companies · 1 sharedDavid T. MaffeiEdward J. Rogers · 1 companies · 1 sharedEdward J. RogersEdward Rogers · 1 companies · 1 sharedEdward RogersJohn T. DiBartolomeo · 1 companies · 1 sharedJohn T. DiBartolo…Michael J. Frank · 1 companies · 1 sharedMichael J. FrankPaul J. Houghton · 1 companies · 1 sharedPaul J. HoughtonRichard J. Berthy · 1 companies · 1 sharedRichard J. BerthyRuben Melendez · 1 companies · 1 sharedRuben MelendezSanket J. Akerkar · 1 companies · 1 sharedSanket J. AkerkarSanket T. Akerkar · 1 companies · 1 sharedSanket T. AkerkarSteven Sherkanowski · 1 companies · 1 sharedSteven Sherkanows…Akumina Inc. · $12.9M raisedAkumina Inc.David J. MaffeiDM
David J. Maffei Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David J. Maffei on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Edward Rogers11
Ruben Melendez11
Steven Sherkanowski11
Ali Diaz11
Edward J. Rogers11
Richard J. Berthy11
Daniel T. Monfried11
Sanket T. Akerkar11
John T. DiBartolomeo11
Michael J. Frank11
David T. Maffei11
Sanket J. Akerkar11
Paul J. Houghton11
Ali J. Riaz11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.